These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35968271)

  • 21. Median Nerve Injury After Removal of Subdermal Implantable Contraceptive.
    Christensen JM; Caggiano NM; Giladi AM; Iorio ML
    Hand (N Y); 2018 May; 13(3):NP6-NP9. PubMed ID: 29185830
    [No Abstract]   [Full Text] [Related]  

  • 22. Six- and twelve-month documented removal rates among women electing postpartum inpatient compared to delayed or interval contraceptive implant insertions after Medicaid payment reform.
    Crockett AH; Pickell LB; Heberlein EC; Billings DL; Mills B
    Contraception; 2017 Jan; 95(1):71-76. PubMed ID: 27400823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case Report: Traumatic Incomplete Fracture of an Implanon NXT® Contraceptive Implant.
    Howett R; Gertz AM; Kgaswanyane T; Petro G; Morroni C
    Afr J Reprod Health; 2019 Dec; 23(4):124-128. PubMed ID: 32227747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
    Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
    Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Removal of nonpalpable etonogestrel implants after fixation with a curved needle-A case series
    El-Hadad S; Villars P; Kahr MK; Leeners B
    Contraception; 2021 Nov; 104(5):577-580. PubMed ID: 34245721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Referral Center Experience With Nonpalpable Contraceptive Implant Removals.
    Matulich MC; Chen MJ; Schimmoeller NR; Hsia JK; Uhm S; Wilson MD; Creinin MD
    Obstet Gynecol; 2019 Oct; 134(4):801-806. PubMed ID: 31503148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Considerations in Adolescent Use of the Etonogestrel Subdermal Implant: A Cohort Study.
    Fei YF; Smith YR; Dendrinos ML; Rosen MW; Quint EH
    Front Reprod Health; 2021; 3():780902. PubMed ID: 36304012
    [No Abstract]   [Full Text] [Related]  

  • 28. Migration of a subdermal contraceptive implant into a subsegmental pulmonary artery and etonogestrel serum concentration over time - a case report.
    Kafi Mallak F; Kopp Kallner H
    Eur J Contracept Reprod Health Care; 2022 Jun; 27(3):261-264. PubMed ID: 35174737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allergic and infectious complications of Etonogestrel implant placements: A case series.
    Osterbur Badhey ML; Li S; Alimena S; Johnson NR; Bartz D
    Contraception; 2023 Jun; 122():109994. PubMed ID: 36871621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real world data on Nexplanon® procedure-related events: final results from the Nexplanon Observational Risk Assessment study (NORA).
    Reed S; Do Minh T; Lange JA; Koro C; Fox M; Heinemann K
    Contraception; 2019 Jul; 100(1):31-36. PubMed ID: 30980829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria.
    Moeti DMP; Govender I; Bongongo T
    S Afr Fam Pract (2004); 2022 Jul; 64(1):e1-e6. PubMed ID: 35924618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Norplant implants in the UK: first year continuation and removals.
    Peers T; Stevens JE; Graham J; Davey A
    Contraception; 1996 Jun; 53(6):345-51. PubMed ID: 8773421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subdermal contraceptive implants.
    Peralta O; Diaz S; Croxatto H
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):223-6. PubMed ID: 7626459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Removal of etonogestrel contraceptive implants in the operating theater: report on 28 cases.
    Vidin E; Garbin O; Rodriguez B; Favre R; Bettahar-Lebugle K
    Contraception; 2007 Jul; 76(1):35-9. PubMed ID: 17586134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Concordance of Telemedicine as Compared With Face-to-Face Care in Primary Health Care Clinics in Rural India: Randomized Crossover Trial.
    Verma N; Buch B; Taralekar R; Acharya S
    JMIR Form Res; 2023 Jun; 7():e42775. PubMed ID: 37130015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Difficult etonogestrel implant removals in South Africa: A review of 74 referred cases.
    Petro G; Spence T; Patel M; Gertz AM; Morroni C
    Contraception; 2020 Aug; 102(2):129-132. PubMed ID: 32339484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects.
    Laurikka-Routti M; Haukkamaa M
    Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. US referral center experience removing nonpalpable and difficult contraceptive implants with in-office ultrasonography: A case series.
    Mastey N; Matulich MC; Uhm S; Baker CC; Melo J; Chen MJ; Creinin MD
    Contraception; 2021 Jun; 103(6):428-430. PubMed ID: 33571492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ENG-releasing subdermal implants in postpartum teenagers - an open-label trial study protocol.
    Barbieri MM; Juliato CRT; Bahamondes L; Surita FG
    Reprod Health; 2020 Jun; 17(1):100. PubMed ID: 32576199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etonogestrel Implant-To Leave or Stay: A Case Series.
    Thew M
    Glob Pediatr Health; 2017; 4():2333794X17738844. PubMed ID: 29204458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.